80 related articles for article (PubMed ID: 3791364)
1. Efficacy of tolciclate solution in patients with tinea pedis.
Gomez EC; Huntley AC; Isseroff R; Tanji J
Clin Ther; 1986; 8(6):694-9. PubMed ID: 3791364
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study.
Ortonne JP; Korting HC; Viguié-Vallanet C; Larnier C; Savaluny E
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1307-13. PubMed ID: 17062050
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the efficacy of ciclopirox 0.77% gel in the treatment of tinea pedis interdigitalis (dermatophytosis complex) in a randomized, double-blind, placebo-controlled trial.
Gupta AK; Skinner AR; Cooper EA
Int J Dermatol; 2005 Jul; 44(7):590-3. PubMed ID: 15985032
[TBL] [Abstract][Full Text] [Related]
4. Double-blind study of the efficacy of 1 week topical terbinafine cream compared to 4 weeks miconazole cream in patients with tinea pedis.
Leenutaphong V; Niumpradit N; Tangwiwat S; Sritaveesuwan R; Muanprasat C
J Med Assoc Thai; 1999 Oct; 82(10):1006-10. PubMed ID: 10561963
[TBL] [Abstract][Full Text] [Related]
5. Tolciclate versus miconazole, a double-blind trial in patients with dermatomycosis.
Cucè LC; Assunção BF; Medawar LG; Salibian A; Groppi W
J Int Med Res; 1980; 8(2):144-7. PubMed ID: 6989684
[TBL] [Abstract][Full Text] [Related]
6. Dose-finding comparative study of 2 weeks of luliconazole cream treatment for tinea pedis--comparison between three groups (1%, 0.5%, 0.1%) by a multi-center randomised double-blind study.
Watanabe S; Takahashi H; Nishikawa T; Takiuchi I; Higashi N; Nishimoto K; Kagawa S; Yamaguchi H; Ogawa H
Mycoses; 2007 Jan; 50(1):35-40. PubMed ID: 17302746
[TBL] [Abstract][Full Text] [Related]
7. Novel, single-dose, topical treatment of tinea pedis using terbinafine: results of a dose-finding clinical trial.
de Chauvin MF; Viguié-Vallanet C; Kienzler JL; Larnier C
Mycoses; 2008 Jan; 51(1):1-6. PubMed ID: 18076588
[TBL] [Abstract][Full Text] [Related]
8. [The antifungal agent naftifin. Placebo-controlled therapeutic comparison in tinea pedis].
Klaschka F; Gartmann H; Weidinger G
Z Hautkr; 1984 Sep; 59(18):1218-26. PubMed ID: 6388170
[TBL] [Abstract][Full Text] [Related]
9. Once daily treatment with terbinafine 1% cream (Lamisil) for one week is effective in the treatment of tinea corporis and cruris. A placebo-controlled study.
Budimulja U; Bramono K; Urip KS; Basuki S; Widodo G; Rapatz G; Paul C
Mycoses; 2001; 44(7-8):300-6. PubMed ID: 11714065
[TBL] [Abstract][Full Text] [Related]
10. Multicentre clinical study with tolciclate in the local treatment of skin mycoses in 1083 patients.
Intini C; Battaglia A; Mangiarotti AM; Picco AM; Viaro D; Sacchetti G
Pharmatherapeutica; 1980; 2(7):439-49. PubMed ID: 7010381
[TBL] [Abstract][Full Text] [Related]
11. Econazole nitrate foam 1% for the treatment of tinea pedis: results from two double-blind, vehicle-controlled, phase 3 clinical trials.
Elewski BE; Vlahovic TC
J Drugs Dermatol; 2014 Jul; 13(7):803-8. PubMed ID: 25007362
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and tolerability of a standardized extract from Ageratina pichinchensis on patients with tinea pedis: an explorative pilot study controlled with ketoconazole.
Romero-Cerecero O; Rojas G; Navarro V; Herrera-Arellano A; Zamilpa-Alvarez A; Tortoriello J
Planta Med; 2006 Nov; 72(14):1257-61. PubMed ID: 17051456
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the efficacy between two itraconazole generic products and the innovative itraconazole in the treatment of tinea pedis.
Hoharitanon S; Chaichalotornkul J; Sindhupak W
J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S167-72. PubMed ID: 16623023
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, vehicle-controlled efficacy and safety study of naftifine 2% cream in the treatment of tinea pedis.
Parish LC; Parish JL; Routh HB; Fleischer AB; Avakian EV; Plaum S; Hardas B
J Drugs Dermatol; 2011 Nov; 10(11):1282-8. PubMed ID: 22052309
[TBL] [Abstract][Full Text] [Related]
15. Usefulness and pharmacokinetic study of oral terbinafine for hyperkeratotic-type tinea pedis.
Kikuchi I; Tanuma H; Morimoto K; Kawana S
Mycoses; 2008 Nov; 51(6):523-31. PubMed ID: 18422915
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of ciclopirox olamine cream for the treatment of tinea pedis: multicenter, double-blind comparative studies.
Clin Ther; 1985; 7(4):409-17. PubMed ID: 3893700
[TBL] [Abstract][Full Text] [Related]
17. A controlled study of haloprogin and tolnaftate in tinea pedis.
Carter VH
Curr Ther Res Clin Exp; 1972 Jun; 14(6):307-10. PubMed ID: 4625803
[No Abstract] [Full Text] [Related]
18. Topical sertaconazole (ertaczo)--another azole for tinea pedis.
Med Lett Drugs Ther; 2004 Jun; 46(1185):50-1. PubMed ID: 15211288
[No Abstract] [Full Text] [Related]
19. Oxiconazole nitrate lotion, 1 percent: an effective treatment for tinea pedis.
Pariser DM; Pariser RJ
Cutis; 1994 Jul; 54(1):43-4. PubMed ID: 7924451
[TBL] [Abstract][Full Text] [Related]
20. Treatment of interdigital-type tinea pedis with a 2-week regimen of wearing hygienic socks loaded with antifungal microcapsules: a randomized, double-blind, placebo-controlled study.
Yuen CW; Yip J; Cheung HC; Liu LW; Luk CH; Wai WC
J Am Acad Dermatol; 2013 Sep; 69(3):495-6. PubMed ID: 23957981
[No Abstract] [Full Text] [Related]
[Next] [New Search]
